In this podcast Micheal Ruscio, DC interviews Chris Meletis, ND on how to safely and effectively utilize cannabidiol (CBD) and medical cannabis in your practice. Most recently Dr. Meletis was featured in the Townsend Letter on a new medical certification program for practitioners prescribing CBD and other active constituents ofRead
Eureka! We’ve been on the search and finally found a refreshingly honest interview on the subject of the endocannabinoid system and the use of cannabidiol in clinical practice. Not surprisingly, it came from Carl Germano, PhD, RD, CNS, CDN. Germano has been in private practice in integrative and nutritional therapiesRead
Could non-psychoactive hemp be a viable use to reduce ovarian cancer risk? As we learn more about the bioactives in hemp, the possibility becomes ever real. At the 2018 annual Experimental Biology meeting in San Diego, graduate students, Sara Biela and Chase Turner, presented the first study to examine hemp andRead
This video, Jeffrey Chen, MD, the Director of the UCLA Cannabis Research Initiative, is the best explanation of the mechanisms and action potential of endocannabinoids in the human body. This is followed by and interview with Raphael Mechoulan, PhD, professor of Medicinal Chemistry at the Hebrew University of Jerusalem. MechoulanRead
Have you been hesitant to prescribe cannabidiol (CBD) because of concerns about gastric acids converting the CBD into psychoactive tetrahydrocannabinol (THC)? In 2016, a study by Merrick et al. suggested that when CBD is exposed to an acidic environment, it degrades to Δ9-tetrahydrocannabinol and other psychoactive cannabinoids. The following isRead
This study is the first demonstration of the anti-inflammatory properties of Cannabidiol in an experimental model for allergic contact dermatitis (ACD). Published in the J. Pharmacology and Experimental Therapeutics, March 2018. Abstract / Phytocannabinoids modulate inflammatory responses by regulating the production of cytokines in several experimental models of inflammation. Cannabinoid type-2Read
Have you thought of prescribing CBD for drug and alcohol recovery? There is new evidence that the non-psychoactive and non-addictive ingredient, cannabidiol (CBD), could help prevent relapses for recovering drug addicts and alcoholics. This preclinical study’s findings provide further evidence about the possible medical benefits of non-psychoactive cannabinoids, and howRead
The endocannabinoid system consists of endogenous cannabinoids (endocannabinoids), cannabinoid receptors and the synthetic and degrading enzymes responsible for synthesis and degradation of endocannabinoids. Endocannabinoids are so named because they were first identified as activating the same receptors as cannabinoids, the primary psychoactive components of cannabis. Published in Journal of Neuroendocrinology 20Read
Recently the Journal of the American Medical Association (JAMA) published two studies and commentary on the relationship between legal cannabis use and opioid prescribing rates and patterns. We provide an 11-minute podcast from the authors and the study abstract summaries below. One study examines state implementation of medical and adult-useRead
Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.
